| PERIOD ENDING | 25-Dec-09 | 25-Sep-09 | 30-Jun-09 | 27-Mar-09 | | Total Revenue | 57,070 | 60,423 | 111,464 | 98,637 | | Cost of Revenue | 49,880 | 50,880 | 99,592 | 87,657 | | | Gross Profit | 7,190 | 9,543 | 11,872 | 10,980 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,371 | 6,678 | 8,102 | 7,318 | | Non Recurring | 424 | 686 |
-
|
-
| | Others | 1,846 | 1,950 | 3,366 | 2,466 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,451) | 229 | 404 | 1,196 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,716 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,451) | 229 | 404 | 1,196 | | Interest Expense | 262 | 264 | 519 | 673 | | Income Before Tax | (1,713) | (35) | (115) | 523 | | Income Tax Expense | (4,481) | 56 | 4,515 | 24 | | Minority Interest | 37 | 27 |
-
|
-
| | | | Net Income From Continuing Ops | 4,493 | (79) | (5,079) | 499 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,493 | (79) | (5,079) | 499 | | Preferred Stock And Other Adjustments | (1,218) | (834) | (215) |
-
| | | Net Income Applicable To Common Shares | $3,275 | ($913) | ($5,294) | $499 |
|
1.52% Nasdaq 0.00%
Income Statement
